The Future for Psychedelic Agents in the Treatment of Posttraumatic Stress Disorder
Amy L Haycraft
The Journal for Nurse Practitioners May 1, 2023 DOI: 10.1016/j.nurpra.2023.104586 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Key findings | Argues that standard PTSD treatments, including trauma-focused cognitive behavioral therapy, eye movement desensitization and reprocessing, and selective serotonin reuptake inhibitors, leave many patients untreated effectively, and suggests that psychedelic-assisted therapy may offer an alternative option if further supportive research is conducted. |
Abstract
Posttraumatic stress disorder (PTSD) treatment options, including the potential use of psychedelic-assisted therapy, are reviewed. Traditional PTSD treatment remains ineffective for many, and includes, trauma focused cognitive behavioral therapy, eye movement desensitization and remodeling, and selective serotonin reuptake inhibitors. Evidence has shown that with further supportive research, psychedelic-assisted therapy may offer an alternative treatment option.